Supplementary Figure S7 from Circulating Tumor DNA Assessment for Treatment Monitoring Adds Value to PSA in Metastatic Castration-Resistant Prostate Cancer
Key Points
Key points are not available for this paper at this time.
Abstract
Prognostic value of 30% PSA reduction
Like
Bookmark
Share
Like
Bookmark
Share
Supplementary Figure S7 from Circulating Tumor DNA Assessment for Treatment Monitoring Adds Value to PSA in Metastatic Castration-Resistant Prostate Cancer | Synapse